Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

980 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Development of 2-(5,6,7-Trifluoro-1H-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate Cancer.
Leblanc E, Ban F, Cavga AD, Lawn S, Huang CF, Mohan S, Chang MEK, Flory MR, Ghaidi F, Lingadahalli S, Chen G, Yu IPL, Morin H, Lallous N, Gleave ME, Mohammed H, Young RN, Rennie PS, Lack NA, Cherkasov A. Leblanc E, et al. Among authors: huang cf. J Med Chem. 2021 Oct 18. doi: 10.1021/acs.jmedchem.1c00681. Online ahead of print. J Med Chem. 2021. PMID: 34661404
Poor Prognosis of Diffuse Large B-Cell Lymphoma with Hepatitis C Infection.
Tsai YF, Liu YC, Yang CI, Chuang TM, Ke YL, Yeh TJ, Gau YC, Du JS, Wang HC, Cho SF, Hsu CM, Wu PF, Huang CI, Huang CF, Yu ML, Dai CY, Hsiao HH. Tsai YF, et al. Among authors: huang cf. J Pers Med. 2021 Aug 27;11(9):844. doi: 10.3390/jpm11090844. J Pers Med. 2021. PMID: 34575621 Free PMC article.
980 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page